152 related articles for article (PubMed ID: 2155804)
1. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors.
Bowen WD; Moses EL; Tolentino PJ; Walker JM
Eur J Pharmacol; 1990 Feb; 177(3):111-8. PubMed ID: 2155804
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H
J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment of rats with the specific sigma ligand D-pentazocine fails to modulate dopamine D2 and sigma binding in brain.
Weissman AD; De Souza EB
Eur J Pharmacol; 1991 Mar; 195(1):163-5. PubMed ID: 1648492
[TBL] [Abstract][Full Text] [Related]
4. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and regulation of 3H-haloperidol binding to rat brain sigma receptors].
Kizu A
Yakubutsu Seishin Kodo; 1991 Apr; 11(2):129-39. PubMed ID: 1656649
[TBL] [Abstract][Full Text] [Related]
6. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
Ericson H; Ross SB
Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
[TBL] [Abstract][Full Text] [Related]
7. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity and antimuscarinic activity of sigma and phencyclidine receptor ligands.
Vargas HM; Pechnick RN
Eur J Pharmacol; 1991 Mar; 195(1):151-6. PubMed ID: 1648491
[TBL] [Abstract][Full Text] [Related]
9. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
11. Interaction of sigma-compounds with receptor-stimulated phosphoinositide metabolism in the rat brain.
Candura SM; Coccini T; Manzo L; Costa LG
J Neurochem; 1990 Nov; 55(5):1741-8. PubMed ID: 2170583
[TBL] [Abstract][Full Text] [Related]
12. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
Entrena JM; Cobos EJ; Nieto FR; Cendán CM; Baeyens JM; Del Pozo E
Psychopharmacology (Berl); 2009 Jul; 205(1):21-33. PubMed ID: 19326101
[TBL] [Abstract][Full Text] [Related]
13. Sigma receptor activation does not mediate fentanyl-induced attenuation of muscarinic coronary contraction.
Tsuchida H; Schubert A; Estafanous FG; Brum JM; Murray PA
Anesth Analg; 1996 May; 82(5):982-7. PubMed ID: 8610910
[TBL] [Abstract][Full Text] [Related]
14. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
Tam SW; Cook L
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
[TBL] [Abstract][Full Text] [Related]
15. Rat cortical sigma receptors differentially regulated by pentazocine and haloperidol.
Kizu A; Yoshida Y; Miyagishi T
J Neural Transm Gen Sect; 1991; 83(1-2):149-53. PubMed ID: 1850284
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of sigma receptors by chronic haloperidol.
Matsumoto RR; Bowen WD; Walker JM
Prog Clin Biol Res; 1990; 328():125-8. PubMed ID: 2154764
[No Abstract] [Full Text] [Related]
17. (-)PPAP: a new and selective ligand for sigma binding sites.
Glennon RA; Battaglia G; Smith JD
Pharmacol Biochem Behav; 1990 Nov; 37(3):557-9. PubMed ID: 1965044
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice.
Itzhak Y; Alerhand S
FASEB J; 1989 May; 3(7):1868-72. PubMed ID: 2541039
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of the novel and selective sigma ligand, PD 144418.
Akunne HC; Whetzel SZ; Wiley JN; Corbin AE; Ninteman FW; Tecle H; Pei Y; Pugsley TA; Heffner TG
Neuropharmacology; 1997 Jan; 36(1):51-62. PubMed ID: 9144641
[TBL] [Abstract][Full Text] [Related]
20. (+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo.
Iyengar S; Wood PL; Mick SJ; Dilworth VM; Gray NM; Farah JM; Rao TS; Contreras PC
Neuropharmacology; 1991 Aug; 30(8):915-22. PubMed ID: 1723511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
